Northland Securities’s Zimmer Biomet ZBH Stock Holding History

Northland Securities’s Portfolio ZBH Stock Details ZBH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$517K	Sell	6,000 -6,000	-50%	-$526K	0.3%	52
2026 Q1	$1.08M	Buy	12,000 +6,000	+100%	+$551K	1.03%	21
2025 Q4	$540K	Buy	+6,000	New	+$569K	0.52%	44

Other funds holding ZBH

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

EIC

Equity Investment Corp Atlanta, Georgia $5.24B AUM 11.32% 1-Year Est. Return

Norges Bank Oslo, Norway $1T AUM

Victory Capital Management San Antonio, Texas $178B AUM 37.23% 1-Year Est. Return

Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

Deutsche Bank Frankfurt Am Main Ge, Germany $344B AUM 42.99% 1-Year Est. Return

Amundi Paris, France $413B AUM 44.57% 1-Year Est. Return

Boston Partners Boston, Massachusetts $113B AUM 38.87% 1-Year Est. Return

Northland Securities's ZBH Position: Q2 2026 in Review

Northland Securities reduced its Zimmer Biomet (ZBH) stake by 50% in Q2 2026, selling an estimated $526K and leaving 6,000 shares worth $517K. The position accounts for 0.3% of the portfolio, ranked #52.

Northland Securities first reported a position in ZBH in Q4 2025 and has held it in 3 quarters since. The position peaked at $1.08M in Q1 2026. 588 funds tracked by Wall St. Rank hold ZBH as of Q2 2026.

Northland Securities held 6,000 shares of Zimmer Biomet worth $517K as of Q2 2026.
Northland Securities sold 6,000 Zimmer Biomet shares in Q2 2026, an estimated $526K.
Zimmer Biomet made up 0.3% of Northland Securities's portfolio in Q2 2026, its #52 holding.
Northland Securities first reported a position in Zimmer Biomet in Q4 2025 and has held it in 3 quarters since.
Northland Securities's Zimmer Biomet position peaked at $1.08M in Q1 2026.
588 funds tracked by Wall St. Rank held Zimmer Biomet as of Q2 2026.

Based on Northland Securities's 13F filing for Q2 2026, filed 4 Aug 2026.